Meta Information

ID:mesenchymal-stem-cell-therapy

Name:Mesenchymal Stem Cell (MSC) Therapy

Schema Version:1.5

Title

Mesenchymal Stem Cell (MSC) Therapy

Alternate Names

• MSCs
• Mesenchymal Stromal Cells
• Stem Cell Therapy

Intervention Type

procedure

Expected Cost Mean

Low Cost:

5000

High Cost:

25000

Cost Type:

one time

Description:

Per-procedure cost for cell sourcing, expansion, and administration.

Summary

Mesenchymal stem cells (MSCs) are multipotent cells that secrete a wide range of anti-inflammatory, immunomodulatory, and regenerative factors. For healthspan, their primary proposed benefit is not replacing old cells, but rather creating a more favorable systemic environment by reducing chronic inflammation (inflammaging) and supporting the body's innate repair mechanisms. This systemic rejuvenation effect is hypothesized to slow the progression of multiple age-related diseases.

Purpose

Reduces systemic inflammation and promotes tissue repair via secreted factors.

Card Summary

Utilizes multipotent cells to reduce systemic inflammation (inflammaging) and promote tissue repair through powerful secreted signaling molecules.

Drug Class

Drugs In Class

Empty Array

Impact

Score:

3.8

Justification:

Theoretically powerful, but lacks robust human data for systemic healthspan extension.

Evidence

Grade:

C

Score:

3.2

Justification:

Strong preclinical data, but human trials focus on disease, not healthspan.

Safety

Score:

7.5

Justification:

Risk of contamination, immune reaction, and highly variable unregulated clinic quality.

Flags

• Largely unregulated in the U.S. for anti-aging; clinic quality varies dramatically.
• Risk of infusion reactions, infection, and transmission of communicable disease.
• Long-term risks, including potential for tumorigenesis, are not well understood.
• Efficacy is highly dependent on cell source, dose, viability, and donor age.
• Contraindicated for individuals with active cancer or certain systemic infections.

Verdict

A high-cost, high-risk frontier with unproven healthspan benefits.

Created

2026-04-23T23:44:54.868667Z

Model

Gemini 3.1 Pro (High)

Delivery

Route:

none

Scope:

• systemic

Indication

Focus:

healthspan

Description:

Mesenchymal stem cells (MSCs) are multipotent cells that secrete a wide range of anti-inflammatory, immunomodulatory, and regenerative factors. For healthspan, their primary proposed benefit is not re...

Typical Protocol

• A single high-dose IV infusion (e.g., 100-300 million cells) performed annually or biennially.
• Localized injections into specific joints or tissues as needed for targeted repair.